SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

Product News   Jan 17, 2018

 
SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells

Product News

Lonza has announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.

READ MORE

Wide Range of Reagent Reservoirs

Product News

Available in 96- and 384-well configurations - Porvair Sciences reagent reservoirs are designed for simple integration into any automated liquid handling system.

READ MORE

New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform Published in Immunity

Product News

TheraT®-induced CD8+ T cells are qualitatively differentiated from CD8+ T cells induced by other vector systems; they have a much higher capacity to kill target cells in tissues.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE